One of these vaccines, AZD1222 (also known as ChAdOx1 nCov-19 and Vaxzevria) is a recombinant replication-deficient non-human adenovirus that encodes the highly immunogenic SARS-CoV-2 spike glycoprotein, which induces specific antibody and T cell responses [26,27]. Available data do not ...
Short-term immune response after inactivated SARS-CoV-2 (CoronaVac(R), Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria(R), Oxford-AstraZeneca) vaccinations in health care workers. Asian Pac J Allergy Immunol 2021. 10.12932/AP-250721-1197 Google Scholar [8] V. Vacharathit, P. Aiewsakun, S. ...